The serum metabolome of COVID-19 patients is distinctive and predictive
Autor: | Jifang Sheng, Silan Gu, Wenrui Wu, Yingfeng Lu, Yanfei Chen, Lanjuan Li, Jiaojiao Xie, Ren Yan, Longxian Lv, Yi-Ling Du, Ding Shi, Huiyong Jiang, Kaijin Xu, Jiafeng Xia, Jing Guo, Chenjie Huang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Male LC-MS liquid chromatography-mass spectrometry Endocrinology Diabetes and Metabolism CK-MB creatine kinase-MB Hydroxybutyrates Butyric acid chemistry.chemical_compound AUC area under the curve 0302 clinical medicine Endocrinology GMP guanosine monophosphate CRP c-reactive protein GGT gamma-glutamyl transpeptidase Prospective Studies Amino Acids Serum metabolome LPV/RTV lopinavir/ritonavir HCs healthy controls COVID-19 coronavirus disease 2019 LDH lactate dehydrogenase TCA cycle tricarboxylic acid cycle Area under the curve INR international normalized ratio Middle Aged PCT procalcitonin Lactic acid Cholesterol GM3s monosialodihexosyl gangliosides Metabolome Female DB direct bilirubin Citric acid Adult medicine.medical_specialty ALT alanine transaminase Predictive value 030209 endocrinology & metabolism Fructose SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 Gas Chromatography-Mass Spectrometry Article WHO World Health Organization 03 medical and health sciences CHOL total cholesterol Internal medicine PT prothrombin time medicine Humans Lactic Acid ALB albumin Aged PPARα peroxisome proliferator-activated receptor alpha business.industry SARS-CoV-2 OPLS-DA orthogonal partial least squares-discriminant analysis COVID-19 Glutamic acid COVID-19 Drug Treatment Oleic acid 030104 developmental biology chemistry COPD chronic obstructive pulmonary disease HBDH hydroxybutyrate dehydrogenase Succinic acid GC–MS gas chromatography–mass spectrometry business |
Zdroj: | Metabolism |
ISSN: | 1532-8600 0026-0495 |
Popis: | Background Metabolism is critical for sustaining life, immunity and infection, but its role in COVID-19 is not fully understood. Methods Seventy-nine COVID-19 patients, 78 healthy controls (HCs) and 30 COVID-19-like patients were recruited in a prospective cohort study. Samples were collected from COVID-19 patients with mild or severe symptoms on admission, patients who progressed from mild to severe symptoms, and patients who were followed from hospital admission to discharge. The metabolome was assayed using gas chromatography–mass spectrometry. Results Serum butyric acid, 2-hydroxybutyric acid, l -glutamic acid, l -phenylalanine, l -serine, l -lactic acid, and cholesterol were enriched in COVID-19 and COVID-19-like patients versus HCs. Notably, d -fructose and succinic acid were enriched, and citric acid and 2-palmitoyl-glycerol were depleted in COVID-19 patients compared to COVID-19-like patients and HCs, and these four metabolites were not differentially distributed in non-COVID-19 groups. COVID-19 patients had enriched 4-deoxythreonic acid and depleted 1,5-anhydroglucitol compared to HCs and enriched oxalic acid and depleted phosphoric acid compared to COVID-19-like patients. A combination of d -fructose, citric acid and 2-palmitoyl-glycerol distinguished COVID-19 patients from HCs and COVID-19-like patients, with an area under the curve (AUC) > 0.92 after validation. The combination of 2-hydroxy-3-methylbutyric acid, 3-hydroxybutyric acid, cholesterol, succinic acid, L-ornithine, oleic acid and palmitelaidic acid predicted patients who progressed from mild to severe COVID-19, with an AUC of 0.969. After discharge, nearly one-third of metabolites were recovered in COVID-19 patients. Conclusions The serum metabolome of COVID-19 patients is distinctive and has important value in investigating pathogenesis, determining a diagnosis, predicting severe cases, and improving treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |